Himachal Pradesh Becomes Third Indian State to Legalize Cannabis Cultivation for Medicinal and Scientific Use
27-Jul-26 07:45:40
In a historic policy shift that promises to give a massive boost to industrial growth, medical research, and traditional pharmaceutical manufacturing, Himachal Pradesh has officially become the third state in India—following Uttarakhand and Madhya Pradesh—to legalize controlled cannabis cultivation for medicinal, scientific, and industrial purposes.
The decision, passed in the state legislative assembly under strictly regulated framework guidelines, allows for the cultivation of non-narcotic industrial hemp as well as low-THC cannabis strains specifically earmarked for pharmaceutical extraction and clinical research.
Economic Relief and Industrial Potential
For Himachal Pradesh, a state currently exploring sustainable revenue models, legalizing cannabis cultivation opens up immense economic possibilities. Industrial hemp and medicinal cannabis are estimated to generate substantial annual revenue for the state exchequer, while creating direct and indirect employment for thousands of local farmers, self-help groups, and agricultural startups.
Key highlights of the state’s new policy include:
-
Strict Regulatory Oversight: Cultivation will be restricted to controlled polyhouses and designated agricultural zones equipped with GPS tracking, strict license quotas, and regular seed testing to ensure low Tetrahydrocannabinol (THC) levels.
-
Industrial Hemp Applications: Apart from medical extractions, industrial hemp fiber will be utilized in eco-friendly textiles, biodegradable plastics, construction materials, and paper manufacturing.
-
R&D Hub Establishment: The government plans to partner with scientific institutions and universities to develop high-yield, disease-resistant seed varieties tailored to the state’s climate.
The Ayurvedic Perspective: Unlocking the Value of 'Vijaya'
This regulatory milestone carries immense significance for traditional Indian medicine. Known as Vijaya or Bhanga in classical Ayurvedic texts, cannabis has been documented for centuries as a potent therapeutic agent when purified (Shodhana) and formulated appropriately.
Classical Ayurvedic formulations utilize Vijaya for managing chronic pain, neurological disorders, digestive ailments, insomnia, and palliative cancer care. However, modern Ayush pharmaceutical manufacturers have long faced severe supply chain bottlenecks due to complex raw material sourcing and legal ambiguities.
The availability of legally cultivated, standardized raw material in Himachal Pradesh is expected to lower production costs for high-grade Ayurvedic formulations and accelerate clinical trials.
This policy shift is also expected to invigorate Ayurveda education and postgraduate research. Scholars specializing in Dravyaguna (Ayurvedic pharmacology) and Rasa Shastra will now have greater access to standardized raw materials for evidence-based research and phytopharmaceutical standardization.
A Boost for Integrative Medicine and Export Potential
With global demand for phytocannabinoids and plant-based therapeutics surging across North America and Europe, Himachal Pradesh’s move positions India to capture a significant share of the international medical cannabis and wellness market.
Stay tuned to our Ayurveda News hub for ongoing policy updates, industrial developments, and scientific breakthroughs across the Ayush sector.
Source: Newindianexpress